Summary
First identified in December 2015 on European NPS markets. Benzofuran analogue of 5-MeO-DiPT with several-fold lower potency. Higher oral doses (>100 mg) frequently cause gastrointestinal discomfort, diarrhea, and restless legs. Notable aphrodisiac and pro-sexual effects reported. Analytical reference spectra available but minimal pharmacokinetic data exists.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 50-80mg | 80-110mg | 110-140mg | 140mg+ |
| Insufflated | 5-10mg | 10-15mg | 15-20mg | 20mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|---|
| Oral | 15-45 min | 15-30 min | 1.0-2.5 hrs | 60-90 min | 5.0 hrs | 4.0-6.0 hrs |
| Insufflated | 1-4 min | 15-30 min | 1.0-2.5 hrs | 60-90 min | 5.0 hrs | - |
Tolerance
Build-up
develops over 1–4 weeks of daily use; hypnotic tolerance faster than anxiolytic tolerance
Reset
weeks to months depending on half-life and duration of use; taper recommended
Effects
Positive
- Stimulation
Negative
- Temperature regulation suppression
- Increased heart rate
- Nausea
- Muscle twitching
- Pupil dilation
- Teeth grinding
- Restless legs
- Spontaneous bodily sensations
- Sedation
Positive
- Analysis enhancement
- Thought connectivity
- Emotion enhancement
- Rejuvenation
- Novelty enhancement
- Conceptual thinking
- Wakefulness
Negative
- Memory suppression
- Time distortion
- Thought acceleration
- Personal bias suppression
- Emotion intensification
Positive
- Bodily control enhancement
- Tactile enhancement
- Increased libido
- Increased music appreciation
- Color enhancement
- Pattern recognition enhancement
- Tracers
- Perception of bodily lightness
- Visual acuity enhancement
- Color shifting
- Auditory acuity enhancement
Negative
- Spontaneous physical sensations
- Closed-eye visuals
- Drifting
- Auditory hallucination
- Auditory distortion
- Tactile intensification